medicaid semaglutide Louisiana lawmakers are considering a bill that would expand access to GLP-1 drugs for obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI As demand for weight-loss drugs

Combination or staged GLP-1 with nutrition therapy Given the existing adherence and cost challenges of GLP-1s coupled with significant weight regain after discontinuation, combination or staged therapy with intensive lifestyle management could promote greater efficacy, cost-effectiveness, and equitable obesity care [3,18,222,[271], [272], [273]]

Long-acting analogs benefit from their extended half-lives in a different way

Examine the cost per serving and decide whether the advantages offset the outlay

SUPPORTS MIND-BODY CONNECTION & HABIT FORMATION: Designed to help reinforce healthy routines by supporting clearer hunger cues and more intentional eating patterns when used alongside a healthy lifestyle

340B Report maintains full editorial independence in its news coverage